课题基金 / 基金详情

CLINICAL TRIAL: EFFECTS OF COENZYME Q10 IN PARKINSON DISEASE (QE#)

CLINICAL TRIAL: EFFECTS OF COENZYME Q10 IN PARKINSON DISEASE (QE#)
临床试验：辅酶 Q10 对帕金森病 (QE
批准号：
8167263
负责人：
ANDREW FEIGIN
金额：
$1.4万
依托单位：
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-04-01 至 2011-03-31
来源：
https://reporter.nih.gov/project-details/8167263
关键词：
AssesClinical TrialsCoenzyme Q10Computer Retrieval of Information on Scientific Projects DatabaseCreatineDoseFundingGrantImpairmentInstitutionParkinson DiseasePatientsPlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

ANDREW FEIGIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a 16-month study to asses the effects of creatine (two doses) versus placebo on slowing the progressive impairment of Parkinson's disease in early untreated patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
CLINICAL TRIAL: A STUDY OF CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE
海外基金